TIFENIE HARRIS: Open Payments
NPI 1558908251 · STANWOOD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 11 payments from 9 companies in 2025. Trend: 2023 $278 · 2024 $215 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Novo Nordisk Inc | 2 | $35 |
| Corium, LLC | 1 | $34 |
| ABBVIE INC. | 1 | $22 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Saxenda, Azstarys, UBRELVY, REXULTI, AIRSUPRA, The Cologuard Plus Collection Kit, FARXIGA, AMVUTTRA.
Industry payments across MI — which companies pay providers there.
